ABCG2 and inflammatory bowel disease: Other notable pathways enriched in cluster 1 (particularly in CD patients) include ‘Glycosphingolipid metabolism’ and ‘ABC transporters in lipid homeostasis’ (Fig. 9d), which are congruous with the known dysregulation of lipid metabolism in IBD coupled with inflammation [50–52].